Recurrent Hepatoblastoma trials recruiting in California

Fewer than 3 recruiting trials found.

All Recurrent Hepatoblastoma trials nationally

Cities in California

Recruiting trials in California

• Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
  NCT04851119 · Phase: Phase 1, Phase 2 · Ages: 12 Months to 30 Years · Sex: All (male and female) · California: Los Angeles, Orange, Palo Alto, San Francisco